
Bio-techne Email Format
Biotechnology Research
・
1,001-2,500 employees
・
Minneapolis, MN, USA
Bio-Techne is a global life sciences company that develops and manufactures reagents, instruments, and diagnostic solutions to empower scientific discovery and advance human health.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@bio-techne.com
Company Overview
Industry
Biotechnology Research
Founded
1976
Headquarters
Minneapolis, MN, USA
Revenue
$1B-$2.5B
FUNDING Stage
Public
Website
Key Executives
Kim Kelderman (President and Chief Executive Officer), Jim Hippel (Executive Vice President - Chief Financial Officer), Gary Latham (Vice President - Chief Technology Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Bio-techne?
Bio-techne uses the first.last format, so Jane Smith would be jane.smith@bio-techne.com.
What are the two main business segments of Bio-techne?
Bio-techne operates through two segments: Protein Sciences, which supplies cytokines, growth factors, antibodies, and immunoassays to biopharma and academic researchers, and Diagnostics and Spatial Biology, which provides spatial biology products, carrier screening kits, and in vitro diagnostic reagents.
How does Bio-techne's Spatial Biology platform serve translational researchers?
Bio-techne's Spatial Biology offering, anchored by the RNAscope assay technology from Advanced Cell Diagnostics and the COMET automated platform from Lunaphore, lets researchers visualize gene and protein expression directly in tissue samples for translational research applications.
Where is Bio-techne headquartered and how many employees does it have?
Bio-techne is headquartered in Minneapolis, MN, and employs approximately 2,852 people. You can use Clay to quickly verify and enrich contact details for specific Bio-techne team members when building a prospect list.
Who is the CEO of Bio-techne in 2026?
Kim Kelderman serves as President and Chief Executive Officer of Bio-techne in 2026, with Jim Hippel as Executive Vice President and Chief Financial Officer supporting the leadership team.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating


